Scroll.in The Jan Vishwas Bill, 2023, passed by Lok Sabha on July 27, is in the news for its lenient approach to the crime of manufacturing “not of standard quality” (NSQ) drugs. But comparatively less attention is being paid to the adverse impact that the legislation will have on an equally serious issue, which is the regulation of pharmacies that have a key role to play in India’s drug supply. To begin...
More »SEARCH RESULT
Total Matching Records found : 288
Poverty and inequality
KEY TRENDS • Oxfam India's 2023 India Supplement report on poverty and inequality in India reveals that the gap between the rich and the poor is widening. Following the pandemic in 2019, the bottom 50 per cent of the population have continued to see their wealth chipped away. By 2020, their income share was estimated to have fallen to only 13 per cent of the national income and have less than 3...
More »US FDA Flags Lapses by Indian Firm's Eye Drops Linked to Vision Loss and Deaths - Tabassum Barnagarwala
Scroll.in The US Food and Drug Administration has found a series of violations in the manufacturing process and sterilisation methods adopted by Global Pharma, the Indian manufacturer of an eye drop that has been linked to 68 cases of eye infection in America, including eight cases of vision loss and three deaths. The company recalled its product, EzriCare Artificial Tears Eye Drop, early in February. The over-the-counter product has been linked to...
More »Can Centralized Regulation Help Drug Quality? - Tauseef Shahidi
Livemint Recent deaths in Gambia, Uzbekistan and the US, allegedly caused by toxic drugs made in India, has the Centre reportedly planning to centralize drug regulation. How effective will this measure be? The Central Drugs Standard Control Organization (CDSCO) is the apex regulatory body. Each state has its own regulator. The state regulators look after licencing and audit manufacturing facilities while CDSCO is responsible for approving new drugs, imports of devices, clinical...
More »WHO Drew Premature Link Between Gambia Child Deaths, Indian Cough Syrups: Drug Regulator
-PTI/ NDTV.com The DCGI said Gambia has informed, according to media, that there has been no direct causal relation established yet between the cough syrup consumption and the deaths. New Delhi: The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe, India's drug regulator has told the global health body. In...
More »
